These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Renal response of anesthetized rats to low-dose infusion of atrial natriuretic peptide. Soejima H, Grekin RJ, Briggs JP, Schnermann J. Am J Physiol; 1988 Sep; 255(3 Pt 2):R449-55. PubMed ID: 2970807 [Abstract] [Full Text] [Related]
8. Effects of a nonpressor analogue of vasopressin on plasma renin activity and salt and water excretion in water-loaded, anesthetized dogs. Malayan SA, Reid IA. Life Sci; 1982 Dec 13; 31(24):2757-63. PubMed ID: 6759835 [Abstract] [Full Text] [Related]
9. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin. Trippodo NC, MacPhee AA, Cole FE. J Hypertens Suppl; 1984 Dec 13; 2(3):S289-91. PubMed ID: 6242556 [Abstract] [Full Text] [Related]
10. The influence of Atriopeptins I and II on the relationship between glomerular filtration and natriuresis. Hansell P, Ulfendahl HR. Acta Physiol Scand; 1987 Mar 13; 129(3):361-9. PubMed ID: 2953172 [Abstract] [Full Text] [Related]
11. Atriopeptins: circulating volume regulatory hormones with potential therapeutic role in chronic renal failure. Cole BR, Schwartz D, Manning PT, Katsube NC, Needleman P. J Hypertens Suppl; 1986 Jun 13; 4(2):S13-6. PubMed ID: 2941535 [Abstract] [Full Text] [Related]
12. Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins. Kompanowska-Jezierska E, Emmeluth C, Grove L, Christensen P, Sadowski J, Bie P. Am J Physiol; 1998 Jun 13; 274(6):R1619-25. PubMed ID: 9608016 [Abstract] [Full Text] [Related]
13. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin. Ganger DR, Gottstein J, Blei AT. J Pharmacol Exp Ther; 1988 Sep 13; 246(3):941-5. PubMed ID: 2971104 [Abstract] [Full Text] [Related]
14. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin. Ishikawa S, Kim JK, Schrier RW. Am J Physiol; 1983 Nov 13; 245(5 Pt 1):R713-9. PubMed ID: 6688929 [Abstract] [Full Text] [Related]
15. Role of atrial natriuretic peptide in mediating the blood pressure-independent natriuresis elicited by systemic inhibition of nitric oxide. Dobrowolski L, Kuczeriszka M, Castillo A, Majid DS, Navar LG. Pflugers Arch; 2015 Apr 13; 467(4):833-41. PubMed ID: 24953240 [Abstract] [Full Text] [Related]
16. Do vasopressin and oxytocin have synergistic renal effects in the conscious rat? Windle RJ, Judah JM, Forsling ML. J Endocrinol; 1995 Mar 13; 144(3):441-8. PubMed ID: 7738468 [Abstract] [Full Text] [Related]
18. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor. Hansell P, Fasching A, Sjöquist M, Andén NE, Ulfendahl HR. Acta Physiol Scand; 1987 Jul 13; 130(3):401-7. PubMed ID: 2957892 [Abstract] [Full Text] [Related]
19. Role of volume status in vasopressin-induced natriuresis: studies in Brattleboro rats. Walter SJ, Tennakoon V, McClune JA, Shirley DG. J Endocrinol; 1996 Oct 13; 151(1):49-54. PubMed ID: 8943768 [Abstract] [Full Text] [Related]